Zinc and its effects on oxidative stress in Alzheimer's disease

Neurological Sciences

Volumn 35, Issue 6, 2014, Pages 923-928

  Yuan, Ye ^a   Niu, Fenglan ^b   Liu, Ya ^b   Lu, Na ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Neurodegeneration; Oxidative stress; Zinc

Indexed keywords

AMYLOID BETA PROTEIN; CHELATING AGENT; CLIOQUINOL; PBT 2; QUINOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ZINC;

ALZHEIMER DISEASE; CHELATION THERAPY; DISEASE COURSE; HOMEOSTASIS; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NEUROTOXICITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; ZINC DEFICIENCY; ZINC METABOLISM; BRAIN; METABOLISM;

ALZHEIMER DISEASE; BRAIN; HOMEOSTASIS; HUMANS; OXIDATIVE STRESS; ZINC;

EID: 84903397869     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-014-1668-x     Document Type: Review

References (64)

1. Bush AI (2008) Drug development based on the metals hypothesis of Alzheimer's disease. J Alzheimers Dis 15:223-240
2. Hao Q, Maret W (2005) Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J Alzheimers Dis 8:161-170 discussion 209-115
3. Hensley K, Hall N, Subramaniam R, Cole P, Harris M et al (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 65:2146-2156
4. Vallee BL, Falchuk KH (1993) The biochemical basis of zinc physiology. Physiol Rev 73:79-118 (Pubitemid 23065434)
5. Frederickson CJ, Koh JY, Bush AI (2005) The neurobiology of zinc in health and disease. Nat Rev Neurosci 6:449-462 (Pubitemid 40774861)
6. Wyllie AH (1997) Apoptosis: an overview. Br Med Bull 53:451-465
7. Yang Y, Jing XP, Zhang SP, Gu RX, Tang FX et al (2013) High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling. PLoS One 8:e55384
8. Paoletti P, Vergnano AM, Barbour B, Casado M (2009) Zinc at glutamatergic synapses. Neuroscience 158:126-136
9. Mayer ML, Vyklicky L Jr (1989) The action of zinc on synaptic transmission and neuronal excitability in cultures of mouse hippocampus. J Physiol 415:351-365 (Pubitemid 19205516)
10. 2+. Neuron 5:781-788
11. Burns A, Iliffe S (2009) Alzheimer's disease. BMJ 338:b158
12. Goedert M, Spillantini MG (2006) A century of Alzheimer's disease. Science 314:777-781 (Pubitemid 44706636)
13. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101-112 (Pubitemid 46432529)
14. Lyubartseva G, Lovell MA (2012) A potential role for zinc alterations in the pathogenesis of Alzheimer's disease. Biofactors 38:98-106
15. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184-185
16. Bush AI (2013) The metal theory of Alzheimer's disease. J Alzheimers Dis 33(Suppl 1):S277-S281
17. Bush AI, Pettingell WH, Multhaup G, d Paradis M, Vonsattel JP et al (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265:1464-1467 (Pubitemid 24306803)
18. Cuajungco MP, Lees GJ (1997) Zinc and Alzheimer's disease: is there a direct link? Brain Res Brain Res Rev 23:219-236 (Pubitemid 27189734)
19. Cuajungco MP, Lees GJ (1997) Zinc metabolism in the brain: relevance to human neurodegenerative disorders. Neurobiol Dis 4:137-169 (Pubitemid 27465507)
20. Zhang LH, Wang X, Stoltenberg M, Danscher G, Huang L et al (2008) Abundant expression of zinc transporters in the amyloid plaques of Alzheimer's disease brain. Brain Res Bull 77:55-60
21. Stoltenberg M, Bush AI, Bach G, Smidt K, Larsen A et al (2007) Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency. Neuroscience 150:357-369 (Pubitemid 350198720)
22. Religa D, Strozyk D, Cherny RA, Volitakis I, Haroutunian V et al (2006) Elevated cortical zinc in Alzheimer disease. Neurology 67:69-75 (Pubitemid 44305464)
23. Bush AI, Pettingell WH Jr, Paradis MD, Tanzi RE (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc. J Biol Chem 269:12152-12158
24. Bush AI, Pettingell WH Jr, de Paradis M, Tanzi RE, Wasco W (1994) The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. J Biol Chem 269:26618-26621
25. Liu ST, Howlett G, Barrow CJ (1999) Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the A beta peptide of Alzheimer's disease. Biochemistry 38:9373-9378
26. Capasso M, Jeng JM, Malavolta M, Mocchegiani E, Sensi SL (2005) Zinc dyshomeostasis: a key modulator of neuronal injury. J Alzheimers Dis 8:93-108 discussion 209-115
27. Zatta P, Lucchini R, van Rensburg SJ, Taylor A (2003) The role of metals in neurodegenerative processes: aluminum, manganese, and zinc. Brain Res Bull 62:15-28 (Pubitemid 37330111)
28. An WL, Bjorkdahl C, Liu R, Cowburn RF, Winblad B et al (2005) Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3b in SH-SY5Y neuroblastoma cells. J Neurochem 92:1104-1115 (Pubitemid 40344301)
29. Sensi SL, Ton-That D, Weiss JH (2002) Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons. Neurobiol Dis 10:100-108 (Pubitemid 34775463)
30. 2+-permeable AMPA/kainate channels triggers prolonged mitochondrial superoxide production. Proc Natl Acad Sci USA 96:2414-2419
31. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21:4183-4187 (Pubitemid 32538543)
32. Smith MA, Sayre LM, Anderson VE, Harris PL, Beal MF et al (1998) Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4- dinitrophenylhydrazine. J Histochem Cytochem 46:731-735 (Pubitemid 28272207)
33. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PL et al (1998) Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70:2212-2215 (Pubitemid 28207848)
34. Maynard CJ, Cappai R, Volitakis I, Laughton KM, Masters CL et al (2009) Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice. Cell Mol Neurobiol 29:757-767
35. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J (1994) Beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 200:710-715
36. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827 (Pubitemid 24187680)
37. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M et al (1994) A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 91:3270-3274
38. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M (1996) beta-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171
39. Bruce AJ, Malfroy B, Baudry M (1996) beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci USA 93:2312-2316 (Pubitemid 26104794)
40. Beal MF (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495-505
41. Bareggi SR, Cornelli U (2012) Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders. CNS Neurosci Ther 18:41-46
42. Greenough MA, Camakaris J, Bush AI (2013) Metal dyshomeostasis and oxidative stress in Alzheimer's disease. Neurochem Int 62:540-555
43. Mao P, Manczak M, Calkins MJ, Truong Q, Reddy TP et al (2012) Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. Hum Mol Genet 21:2973-2990
44. Torres LL, Quaglio NB, de Souza GT, Garcia RT, Dati LM et al (2011) Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 26:59-68
45. Vina J, Lloret A, Orti R, Alonso D (2004) Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress. Mol Asp Med 25:117-123 (Pubitemid 38401936)
46. Powell SR (2000) The antioxidant properties of zinc. J Nutr 130:1447S-1454S
47. Gibbs PN, Gore MG, Jordan PM (1985) Investigation of the effect of metal ions on the reactivity of thiol groups in human 5-aminolaevulinate dehydratase. Biochem J 225:573-580 (Pubitemid 15174246)
48. Da Silva JJR (1991) Zinc: Lewis acid catalysis and regulation. In: Williams RJ (ed) The Biological Chemistry of the Elements. Clarendon Press, Oxford, pp 299-318
49. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT et al (2000) Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275:19439-19442 (Pubitemid 30441532)
50. Perry DK, Smyth MJ, Stennicke HR, Salvesen GS, Duriez P et al (1997) Zinc is a potent inhibitor of the apoptotic protease, cas-pase-3. A novel target for zinc in the inhibition of apoptosis. J Biol Chem 272:18530-18533 (Pubitemid 27318188)
51. Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN (1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death. Semin Cancer Biol 4:327-332 (Pubitemid 2028596)
52. 2+ permeable AMPA channels and consequent ROS production. Neuroreport 10:1723-1727
53. 2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells. J Neurochem 78:600-610
54. Noh KM, Koh JY (2000) Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20:RC111
55. 2+ pools. Proc Natl Acad Sci USA 100:6157-6162
56. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD (2001) The role of zinc in caspase activation and apoptotic cell death. Biometals 14:315-330 (Pubitemid 34066635)
57. Dineley KE, Votyakova TV, Reynolds IJ (2003) Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration. J Neurochem 85:563-570 (Pubitemid 36534479)
58. Corona C, Pensalfini A, Frazzini V, Sensi SL (2011) New therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc. Cell Death Dis 2:e176
59. Adlard PA, Cherny RA, Finkelstein DI, Gautier E, Robb E et al (2008) Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 59:43-55 (Pubitemid 351905863)
60. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD et al (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30:665-676 (Pubitemid 32607332)
61. Ritchie CW, Bush AI, Mackinnon A, Macfarlane S, Mastwyk M et al (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch Neurol 60:1685-1691 (Pubitemid 37521621)
62. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J (2009) A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses. J Neurosci 29:4004-4015
63. Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D et al (2008) Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol 7:779-786
64. Faux NG, Ritchie CW, Gunn A, Rembach A, Tsatsanis A et al (2010) PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis 20:509-516